Lysine methyltransferase 2D deficiency drives complete response to pembrolizumab in PD-L1-High cholangiocarcinoma: a case report and review of literature
BackgroundIntrahepatic cholangiocarcinoma (ICC) typically exhibits poor responsiveness to immune checkpoint inhibitors (ICIs) due to its microsatellite-stable (MSS) status and low tumor mutational burden (TMB). Conventional biomarkers like PD-L1 expression show limited predictive value, creating an...
Saved in:
| Main Authors: | Xiaofang Li, Liao Wang, Shuang Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1616361/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
by: Yoshitaka Shimamaki, et al.
Published: (2024-02-01) -
Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature
by: Kyohei Yugawa, et al.
Published: (2018-11-01) -
Cystatin B Promotes the Proliferation, Migration, and Invasion of Intrahepatic Cholangiocarcinoma
by: Dai Zhang, et al.
Published: (2025-01-01) -
Primary Cholangiocarcinoma of the Liver Presenting as a Complicated Hepatic Cyst: A Diagnostic Challenge
by: Chang Won Ha, et al.
Published: (2025-01-01) -
A case report of a rare intrahepatic cholangiocarcinoma with rectal metastasis
by: Shu-min Jiang, et al.
Published: (2025-06-01)